ArticleJournal of the National Cancer Institute2013

Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes.

Rinki Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.